Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix - Wikidata - wikimedia - TriplyDB

Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix

Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix

http://www.wikidata.org/entity/Q24246593

about

Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer Palliative interventions for controlling vaginal bleeding in advanced cervical cancer Chemotherapy for metastatic and recurrent cervical cancer Palliative interventions for controlling vaginal bleeding in advanced cervical cancer Adjuvant chemotherapy after concurrent chemoradiation for locally advanced cervical cancer Primary surgery versus primary radiotherapy with or without chemotherapy for early adenocarcinoma of the uterine cervix Adjuvant platinum-based chemotherapy for early stage cervical cancer Adjuvant chemotherapy for endometrial cancer after hysterectomy Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: individual patient data meta-analysis Primary surgery versus primary radiation therapy with or without chemotherapy for early adenocarcinoma of the uterine cervix Chemotherapy for metastatic and recurrent cervical cancer Therapy of human papillomavirus-related disease Feasibility and effect of ultrasound microbubble-mediated wild-type p53 gene transfection of HeLa cells Reduced cervical cancer incidence and mortality in Canada: national data from 1932 to 2006.Reducing uncertainties about the effects of chemoradiotherapy for cervical cancer: a systematic review and meta-analysis of individual patient data from 18 randomized trials.Weekly cisplatin or gemcitabine concomitant with radiation in the management of locally advanced carcinoma cervix: results from an observational study Impact of bone marrow radiation dose on acute hematologic toxicity in cervical cancer: principal component analysis on high dimensional data Strain elastography imaging for early detection and prediction of tumor response to concurrent chemo-radiotherapy in locally advanced cervical cancer: feasibility study Biological Features of Human Papillomavirus-related Head and Neck Cancers Contributing to Improved Response.Concurrent Chemoradiotherapy without Brachytherapy in Locally Advanced Cervical Cancer.The impact of lymph node density on survival of cervical cancer patients.A phase II randomized trial comparing radiotherapy with concurrent weekly cisplatin or weekly paclitaxel in patients with advanced cervical cancer.Proteomic biomarkers predicting lymph node involvement in serum of cervical cancer patients. Limitations of SELDI-TOF MS.Late GI and bladder toxicities after radiation for uterine cancer.Adjuvant platinum-based chemotherapy for early stage cervical cancer.Radiosensitizers in cervical cancer. Cisplatin and beyond.The effect of interleukin 36 gene therapy in the regression of tumor.Radiation-sparing managements for cervical cancer: a developing countries perspective.Utility of preoperative ferumoxtran-10 MRI to evaluate retroperitoneal lymph node metastasis in advanced cervical cancer: Results of ACRIN 6671/GOG 0233.Long-term follow-up results of simultaneous integrated or late course accelerated boost with external beam radiotherapy to vaginal cuff for high risk cervical cancer patients after radical hysterectomy.Optimization of near-infrared fluorescent sentinel lymph node mapping in cervical cancer patients.Contribution of pelvic and para-aortic lymphadenectomy with sentinel node biopsy in patients with IB2-IIB cervical cancer.Effect of changes in treatment practice on survival for cervical cancer: results from a population-based study in Manitoba, Canada.The relevance of molecular biomarkers in cervical cancer patients treated with radiotherapy.Novel approaches for concurrent irradiation in locally advanced cervical cancer: platinum combinations, non-platinum-containing regimens, and molecular targeted agents.Brachytherapy versus radical hysterectomy after external beam chemoradiation: a non-randomized matched comparison in IB2-IIB cervical cancer patients The Microenvironment of Cervical Carcinoma Xenografts: Associations with Lymph Node Metastasis and Its Assessment by DCE-MRI.Global radiation oncology waybill.Novel predictive biomarkers for cervical cancer prognosis.Rigosertib is a more effective radiosensitizer than cisplatin in concurrent chemoradiation treatment of cervical carcinoma, in vitro and in vivo.

P2860

Q24187473-5FA16ED4-2A25-4E53-85DD-1E5A726DE528 Q24188092-494A8576-7666-4B25-9993-81B68E477659 Q24198084-73E327B7-6A0F-45F7-92A4-66F0A4D00DEB Q24200725-5BE06DE6-0862-412D-BEE6-A3D3F86AE25F Q24201198-336498C5-212C-43AE-AABD-635BD3E2E7DB Q24201754-8778B7C8-DAC0-458F-BEF8-6549D450916E Q24202602-27705971-82EF-4C83-98FE-03B917BE3796 Q24236277-13EAC5B2-D31E-488E-B8D3-BB45ED64422F Q24240382-A0390886-ACF3-407A-AAB8-5D7D0377F0C9 Q24241058-20520807-9D18-485E-917C-406486F9293C Q24245780-FAE750BC-2FA4-4557-943E-9D7AF92299A6 Q27007473-6F1B9035-40DC-4948-878D-8EDBA45232A9 Q30463703-E7DDF75F-5D6A-4576-9F42-2C991744707F Q30577708-4DF183E2-3A43-4F30-9F73-0AEF116775B0 Q33383729-4EABF157-B558-4A53-8CCC-86C95176E823 Q33560988-74026F9F-6CC3-4942-92C6-FE0733002EFC Q33578833-8B6CA960-438E-49A1-B693-A36CE2A00A56 Q33814902-01118BA5-E155-410F-BEC5-9F0F767611AC Q33908290-496AE1FF-9D32-48FD-AC5A-F0F67EB4D032 Q34082463-3540FCAA-E00D-4A66-AA4B-E8766FC5BD6B Q34122743-8A98219A-67E9-4AD1-A4E7-00C53707AA8D Q34202723-CD9FC151-DAB7-4A4D-B6B2-9D19A570BA3B Q34302950-57ECC0D3-D2C6-46DC-8E36-749BB2381BF6 Q34516623-53A748F6-F48E-4CB7-8F9F-0A52E49EC9CA Q34545322-839F4CCF-8633-4132-B7EF-6A4E87F35F3D Q34684307-096041FE-E99E-4046-B542-D3DC0A6388A6 Q35015898-8D03B938-03A9-4162-9500-A4DF0DA06F3C Q35165643-351BC25C-C8A3-4FE8-8B70-D3A6850C40B6 Q35170100-B88F06C3-D0BA-49DE-9993-7578FE272AA8 Q35425510-FCF0E112-67B7-4305-9D24-410FCED2FFDB Q35457413-6B7E3603-22F8-4148-816B-DC72948C43DF Q35653892-B1FED892-894A-4582-B073-3016138F4882 Q35783868-76E10B76-BEAC-4C41-815A-B361259DC628 Q36241881-DA9BAFB8-C190-4E5C-BEE5-180EB6844738 Q36908043-98F3893B-9A88-4927-8565-24D850B8DDC8 Q37114187-3153A73E-0207-4FF4-B116-628D28D87392 Q37236037-04EFA45E-580B-45C5-BABB-D1E91FB646CE Q37392311-D073166A-03BA-40BD-99F3-451CB29E0977 Q37581821-C30B9790-CCD9-4087-8A7D-A3F8DC9012F9 Q37733073-0CE6646A-CF91-45E0-A14E-5E05B1643F17

P2860

Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix

http://www.wikidata.org/entity/Q24246593

description

2005 nî lūn-bûn

@nan

2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix

@ast

Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix

@en

Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix

@en-gb

Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix

@nl

type

label

Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix

@ast

Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix

@en

Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix

@en-gb

Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix

@nl

prefLabel

Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix

@ast

Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix

@en

Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix

@en-gb

Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix

@nl

P1433

Q24246593-3EA1499B-859D-476F-9343-08655E2F4642

P1476

Q24246593-0A1AE57C-8EDE-4F5D-8D6A-43AE53D6AFB6

P2093

Q24246593-1E03A5BF-8560-47CB-8449-F205E893113D

Q24246593-83C64005-AD83-44D2-8829-51E3AF64E16F

Q24246593-8B5AC4C0-7A01-467F-967B-75EA7055279C

Q24246593-A9A191B7-6CCE-4CE8-91B2-F26B23B7B53E

Q24246593-B88FC5F1-3766-4BA0-9640-8FC2A2B54420

Q24246593-C22AEF8D-C487-4D74-B003-CFCF4D3DBD6B

Q24246593-D2626439-82BE-48E5-A188-6FBAE0294DEB

P2860

Q24246593-03FA1675-7E74-4B38-B12D-7831EF391D29

Q24246593-3680664B-40EA-41A0-BE80-257F4158720A

Q24246593-3E3C592A-4E14-4C7E-BE40-00536608D063

Q24246593-409D3F9E-FF34-48F0-978C-DE51037D448B

Q24246593-433E1D74-C28A-4044-8D7D-82D578CB522A

Q24246593-517CBAE9-7682-43A6-AB87-0251DF4FA246

Q24246593-5787DDB0-0C69-4BA7-B4EF-146447267EBB

Q24246593-6150563E-1EC3-4ABF-B54F-F5E2116D8122

Q24246593-6D270711-8FC9-4B86-B000-F7E09530833C

Q24246593-797464A6-E6A7-4155-B87C-14D8FF44AD74

P31

Q24246593-39c46992-1ad6-4f18-8d02-2cdc513bc445

Q24246593-E2505F0E-89E7-4582-81B8-0301F9139807

P356

Q24246593-84452098-E6CB-42E2-B609-0E38C4CD3712

P50

Q24246593-94E4B600-AD64-4F3C-B4DF-F40E2AB62D4E

P577

Q24246593-FF383572-0AA5-4608-9EBD-2FDBD8C1A2C2

P698

Q24246593-48E247D6-46B3-4592-BEE9-041D3E014EB5

P921

Q24246593-B7A773BE-2245-4B8C-B842-ECAB653F64D9

Q24246593-CCF4D115-7C84-4538-BE6C-0A62023DD8C6

P356

14651858.CD002225.PUB2

P1433

Cochrane Database of Systematic Reviews

P1476

Concomitant chemotherapy and radiation therapy for cancer of the uterine cervix

@en

P2093

Chris Williams

http://www.w3.org/2001/XMLSchema#string

Claire L Vale

http://www.w3.org/2001/XMLSchema#string

John A Green

http://www.w3.org/2001/XMLSchema#string

John J Kirwan

http://www.w3.org/2001/XMLSchema#string

Lydia L Fresco

http://www.w3.org/2001/XMLSchema#string

Mandy Collingwood

http://www.w3.org/2001/XMLSchema#string

Paul R Symonds

http://www.w3.org/2001/XMLSchema#string

P2860

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

Publication bias in clinical research

Neoadjuvant chemotherapy for locally advanced cervical cancer: a systematic review and meta-analysis of individual patient data from 21 randomised trials.

Weekly cisplatin and radical radiation therapy for advanced, recurrent, and poor prognosis cervical carcinoma.

The existence of publication bias and risk factors for its occurrence.

Beta blockade during and after myocardial infarction: an overview of the randomized trials.

Concomitant hydroxyurea plus radiotherapy versus radiotherapy for carcinoma of the uterine cervix: a systematic review.

Trends in cervical cancer and carcinoma in situ in Great Britain

Factors influencing publication of research results. Follow-up of applications submitted to two institutional review boards.

Estimates of the worldwide mortality from 25 cancers in 1990.

P31

scholarly article

P356

10.1002/14651858.CD002225.PUB2

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-07-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

16034873

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy